−10.92PLN
−25.60 MPLN
662.00 KPLN
2.74 M
About PURE
Sector
Industry
CEO
Filip Jan Jelen
Website
Headquarters
Wroclaw
Employees (FY)
96
Founded
2010
ISIN
PLPRBLG00010
FIGI
BBG00MS3WV19
Pure Biologics SA engages in the research and development of biological drug and non-systemic therapies. It focuses on immuno-oncology, autoimmunology, and rare neurological diseases. The company was founded by Filip Jan Jelen, Maciej Piotr Mazurek, Piotr Jan Jakimowicz, Jacek Józef Otlewski, and Andrzej Jan Trznade and in 2010 and is headquartered in Wroclaw, Poland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PUR is 8.02 PLN — it has decreased by 3.37% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on GPW exchange PURE stocks are traded under the ticker PUR.
Yes, you can track PURE financials in yearly and quarterly reports right on TradingView.
Like other stocks, PUR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PURE stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 96.00 employees. See our rating of the largest employees — is PURE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PURE EBITDA is −43.02 M PLN, and current EBITDA margin is −5.29 K%. See more stats in PURE financial statements.